نتایج جستجو برای: 68ga

تعداد نتایج: 1443  

2014
Matthias Eder Oliver Neels Miriam Müller Ulrike Bauder-Wüst Yvonne Remde Martin Schäfer Ute Hennrich Michael Eisenhut Ali Afshar-Oromieh Uwe Haberkorn Klaus Kopka

The detection of prostate cancer lesions by PET imaging of the prostate-specific membrane antigen (PSMA) has gained highest clinical impact during the last years. 68Ga-labelled Glu-urea-Lys(Ahx)-HBED-CC ([68Ga]Ga-PSMA-HBED-CC) represents a successful novel PSMA inhibitor radiotracer which has recently demonstrated its suitability in individual first-in-man studies. The radiometal chelator HBED-...

2016
Elise Verger Pierre Drion Geneviève Meffre Claire Bernard Luc Duwez Nicolas Lepareur Olivier Couturier François Hindré Roland Hustinx Franck Lacoeuille

PURPOSE This work aims to develop, validate and optimize the radiolabeling of Starch-Based Microparticles (SBMP) by 188Re and 68Ga in the form of ready-to-use radiolabeling kits, the ultimate goal being to obtain a unique theranostic vector for the treatment of Hepatocellular Carcinoma. METHODS Optimal labeling conditions and composition of freeze-dried kits were defined by monitoring the rad...

Journal: :asia oceania journal of nuclear medicine and biology 0
mojdeh naderi department of chemistry, university of zanjan, zanjan, iran samaneh zolghadri nuclear science and technology research institute (nstri), tehran, iran hassan yousefnia nuclear science and technology research institute (nstri), tehran, iran ali ramazani department of chemistry, university of zanjan, zanjan, iran amir reza jalilian nuclear science and technology research institute (nstri), tehran, iran

objective(s): gallium-68 dota-dphe1-tyr3-octreotide (68ga-dotatoc) has been applied by several european centers for the treatment of a variety of human malignancies. nevertheless, definitive dosimetric data are yet unavailable. according to the society of nuclear medicine and molecular imaging, researchers are investigating the safety and efficacy of this radiotracer to meet food and drug admin...

Objective(s): Gallium-68 DOTA-DPhe1-Tyr3-Octreotide (68Ga-DOTATOC) has been applied by several European centers for the treatment of a variety of human malignancies. Nevertheless, definitive dosimetric data are yet unavailable. According to the Society of Nuclear Medicine and Molecular Imaging, researchers are investigating the safety and efficacy of this radiotracer to meet Food and Drug Admin...

Journal: :Radioisotopes 1986
M Yamashita H Horii M Hashiba Y Imahori N Mizukawa

An ionic generator1) has been developed for preparation of gallium-68-labeled radiopharmaceuticals. This generator can be easily applied to the preparation of 68Ga-EDTA but some trials are necessary to determine the proper doses of EDTA. The half life of 68Ga is about 68 min and in our experiments, as it was necessary to check the purity of many samples at one time, we employed simplified mini ...

2016
Jaime Retamal Jens Sörensen Mark Lubberink Fernando Suarez-Sipmann João Batista Borges Ricardo Feinstein Sirpa Jalkanen Gunnar Antoni Göran Hedenstierna Anne Roivainen Anders Larsson Irina Velikyan

There is an unmet need for noninvasive, specific and quantitative imaging of inherent inflammatory activity. Vascular adhesion protein-1 (VAP-1) translocates to the luminal surface of endothelial cells upon inflammatory challenge. We hypothesized that in a porcine model of acute respiratory distress syndrome (ARDS), positron emission tomography (PET) with sialic acid-binding immunoglobulin-like...

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2016
Eung Ju Kim Sungeun Kim Hong Seog Seo Yong Jik Lee Jae Seon Eo Jae Min Jeong Boeun Lee Jae Young Kim Young Mi Park Myeongsook Jeong

Activated macrophages take up 18F-FDG via glucose transporters, so this compound is useful for atherosclerosis imaging by PET. However, 18F-FDG application is limited for imaging of the heart and brain, in which glucose uptake is high, and in patients with aberrant glucose metabolism. The aims of this study were to confirm that mannosylated human serum albumin (MSA) specifically binds to the ma...

2017
Silvia Migliari Antonino Sammartano Maura Scarlattei Giulio Serreli Caterina Ghetti Carla Cidda Giorgio Baldari Ornella Ortenzia Livia Ruffini

Background: Prostate-specific membrane antigen (PSMA) has gained high attention as a useful biomarker in the imaging evaluation of prostate cancer with positron emission tomography (PET) during recent years. [68Ga]-labeled Glu-urea-Lys(Ahx)-HBED-CC ([68Ga]-PSMA-HBED-CC) is a novel PSMA inhibitor radiotracer which has demonstrated its suitability in detecting prostate cancer. Preparation conditi...

2018
K Schiller M Devecka T Maurer M Eiber J Gschwend M Schwaiger S E Combs G Habl

BACKGROUND 68Ga-PSMA-PET-imaging has proven to be a highly sensitive and specific diagnostic element for patients with prostate cancer (PC). Does the standard clinical target volume (CTV) cover the majority of 68Ga-PSMA-PET detected lymph nodes (LNs) in a primary setting? METHODS 25 out of 159 patients with primary PC who underwent 68Ga-PSMA-PET-imaging were analyzed in the process of this st...

2014
Uwe Haberkorn

INTRODUCTION Prostate specific membrane antigen (PSMA) has become an attractive diagnostic and therapeutic target for small molecule ligands. Radionuclide-chelating ligands can be labeled with either 68Ga for positron-emission-tomography (PET) or 177Lu for radionuclide therapy. Areas covered: In this literature review we evaluate the diagnostic value of 68Ga PSMA PET/CT and the therapeutic pote...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید